These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 14562199)

  • 1. [Vasoconstrictive Therapies for Bleeding Esophageal Varices and their Mechanisms of Action].
    Döhler KD; Walker S; Mentz P; Forssmann K; Staritz M
    Z Gastroenterol; 2003 Oct; 41(10):1001-16. PubMed ID: 14562199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin analogues in the treatment of hepatorenal syndrome and gastrointestinal haemorrhage.
    Döhler KD; Meyer M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):335-50. PubMed ID: 18683479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin, somatostatin analogues and other vasoactive drugs in the treatment of bleeding oesophageal varices.
    de Franchis R
    Dig Liver Dis; 2004 Feb; 36 Suppl 1():S93-100. PubMed ID: 15077917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide and bleeding oesophageal varices: new indication. Nothing new.
    Prescrire Int; 1999 Aug; 8(42):113-4. PubMed ID: 11503829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage.
    Seo YS; Park SY; Kim MY; Kim JH; Park JY; Yim HJ; Jang BK; Kim HS; Hahn T; Kim BI; Heo J; An H; Tak WY; Baik SK; Han KH; Hwang JS; Park SH; Cho M; Um SH
    Hepatology; 2014 Sep; 60(3):954-63. PubMed ID: 24415445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug therapy of hemorrhage in esophageal and gastric varices: role of vasoactive drugs].
    Pulanić R
    Lijec Vjesn; 2000; 122(11-12):276-83. PubMed ID: 11291271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review article: a critical comparison of drug therapies in currently used therapeutic strategies for variceal haemorrhage.
    Nevens F
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():18-22; discussion 23. PubMed ID: 15335394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.
    Saner FH; Canbay A; Gerken G; Broelsch CE
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):207-17. PubMed ID: 19072411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of variceal bleeding in patients with cirrhosis.
    Abraldes JG; Dell'Era A; Bosch J
    Can J Gastroenterol; 2004 Feb; 18(2):109-13. PubMed ID: 14997222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of variceal pressure by continuous non-invasive endoscopic registration: a placebo controlled evaluation of the effect of terlipressin and octreotide.
    Nevens F; Van Steenbergen W; Yap SH; Fevery J
    Gut; 1996 Jan; 38(1):129-34. PubMed ID: 8566840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of splanchnic vasoconstrictors and endoscopic band ligation is an effective treatment strategy for acute variceal hemorrhage; but how do we get those drugs approved by the FDA?
    Fortune BE; Groszmann RJ
    Hepatology; 2014 Sep; 60(3):789-91. PubMed ID: 24700393
    [No Abstract]   [Full Text] [Related]  

  • 13. Terlipressin vs. somatostatin in bleeding esophageal varices: a controlled, double-blind study.
    Walker S; Kreichgauer HP; Bode JC
    Hepatology; 1992 Jun; 15(6):1023-30. PubMed ID: 1350562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A discussion of how terlipressin limits mortality in cases of bleeding oesophageal varices.
    Lebrec D
    Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):549-52. PubMed ID: 9855076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to the management of bleeding esophageal varices: role of somatostatin.
    Avgerinos A
    Digestion; 1998; 59 Suppl 1():1-22. PubMed ID: 9603441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.
    D'Amico G; Pagliaro L; Pietrosi G; Tarantino I
    Cochrane Database Syst Rev; 2010 Mar; 2010(3):CD002233. PubMed ID: 20238318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of acute variceal bleeding.
    Lata J; Hulek P; Vanasek T
    Dig Dis; 2003; 21(1):6-15. PubMed ID: 12837994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin (glypressin) versus somatostatin in the treatment of bleeding esophageal varices--final report of a placebo-controlled, double-blind study.
    Walker S; Kreichgauer HP; Bode JC
    Z Gastroenterol; 1996 Oct; 34(10):692-8. PubMed ID: 8921578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No difference in mortality between terlipressin and somatostatin treatments in cirrhotic patients with esophageal variceal bleeding and renal functional impairment.
    Hung TH; Tsai CC; Tseng CW; Tseng KC; Hsieh YH; Tsai CC
    Eur J Gastroenterol Hepatol; 2016 Nov; 28(11):1275-9. PubMed ID: 27455080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of analogues: successes and failures.
    Bosch J; Lebrec D; Jenkins SA
    Scand J Gastroenterol Suppl; 1998; 226():3-13. PubMed ID: 9595598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.